SMP-869

N/A

Report date: 2024/11/26 17:30:43

Base Information

Drug NameSMP-869

Drug Alias NameSMP-869

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Eribulin payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionTubulin inhibitorsAnti-CD276

TargetsTubulinCD276 antigen

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesChengdu Xilinglab Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Xilinglab Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A